RS
Rajesh Salwan
About Rajesh Salwan
Data last updated:
Rajesh Salwan is an Additional Director at Apotex Research Private Limited (since 2025). The companies operate in Pharma and Chemicals and Materials. Apotex Research Private Limited reported revenue of ₹727 Cr (FY 2025). Earlier, Rajesh Salwan was an Additional Director at Sudarshan Dahej Mfg Private Limited (2023–2024) and Director at Centrient Pharmaceuticals India Private Limited (2016–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 18 Mar 2025 | 2003 | ₹727 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 31 Oct 2023 | 2020 | ₹17.92 Cr (FY 2025) | Active | |
| Director | 08 Dec 2016 | 1993 | ₹2,240 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Salwan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brian George Mcclelland | 06568789 | Apotex Research Private Limited | Director |
| Goutam Vilas Pujari | 02891339 | Apotex Research Private Limited | Director |
| Shama Shridhar Doddawad | Apotex Research Private Limited | Cfo | |
| Uta Kellermann Renton | 10993254 | Apotex Research Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Salwan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Salwan
Rajesh Salwan currently holds 1 directorship: Apotex Research Private Limited (Additional Director, since 18 Mar 2025, revenue ₹727 Cr (FY 2025)).
Rajesh Salwan was first appointed on 08 Dec 2016 as Director at Centrient Pharmaceuticals India Private Limited. The most recent appointment on record is 18 Mar 2025 at Apotex Research Private Limited.
Rajesh Salwan held 2 earlier board appointments: Sudarshan Dahej Mfg Private Limited (Additional Director, 31 Oct 2023 to 28 May 2024); Centrient Pharmaceuticals India Private Limited (Director, 08 Dec 2016 to 25 Aug 2020).
The current boards of Rajesh Salwan's companies include Brian George Mcclelland (Apotex Research Private Limited), Goutam Vilas Pujari (Apotex Research Private Limited), Shama Shridhar Doddawad (Apotex Research Private Limited), Uta Kellermann Renton (Apotex Research Private Limited).